Learn about CVE-2020-27256, a vulnerability in SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i, and AnyDana-A insulin pumps allowing unauthorized access to change therapy settings.
In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i, and AnyDana-A, a hard-coded physician PIN in the physician menu of the insulin pump allows attackers with physical access to change insulin therapy settings.
Understanding CVE-2020-27256
This CVE involves a vulnerability in SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i, and AnyDana-A that could be exploited by attackers with physical access to the insulin pump.
What is CVE-2020-27256?
The vulnerability in the insulin pump's physician menu allows unauthorized individuals to modify insulin therapy settings due to a hard-coded physician PIN.
The Impact of CVE-2020-27256
The presence of a hard-coded physician PIN poses a significant security risk as attackers with physical access can alter critical insulin therapy settings, potentially endangering the patient's health.
Technical Details of CVE-2020-27256
This section provides more in-depth technical insights into the vulnerability.
Vulnerability Description
The vulnerability involves a hard-coded physician PIN within the physician menu of the affected insulin pump models, enabling unauthorized access to and modification of insulin therapy settings.
Affected Systems and Versions
Exploitation Mechanism
Attackers with physical access to the insulin pump can exploit the hard-coded physician PIN in the physician menu to change insulin therapy settings.
Mitigation and Prevention
Protecting against and addressing the CVE-2020-27256 vulnerability is crucial for ensuring the security of affected devices.
Immediate Steps to Take
Long-Term Security Practices
Patching and Updates